Ochre Bio Announces Formation of Scientific Strategy Board w

Ochre Bio, an RNA therapeutics company focused on chronic liver and cardiometabolic diseases, announced today the formation of its scientific strategy board (SSB) to support the maturation of its platforms

Related Keywords

China , Chas Bountra , Kostenloser Wertpapierhandel , Chinwe Ukomadu , Sangeeta Bhatia Wilson , Alexk Shalek , Eduardo Martins , Allergan Abbvie , Division Of Liver Diseases , Broad Institute , Santaris Pharmaceuticals , Ragon Institute , Institute Member , Novartis , Extramural Member Of The Koch Institute , Oxford University , Clinical Development , Head Of Development , Ochre Bio , Bhatia Wilson Professor , Area Unit , Bountra Pro Vice Chancellor , Innovation Professor , Translational Medicine , Friedman Professor , Liver Diseases , Mount Sinai , Dale Head , Strategic Partnerships Unit , Greater China , Dudley Partner , Innovation Endeavors , Chief Scientific Officer , Tempus Labs , Hodson Professor , Metabolic Physiology , Martins Chief Medical Officer , Core Member , Associate Professor , Extramural Member , Koch Institute , Quin Wills , Chief Scientific Officer Co Founder , Pro Vice Chancellor , Ochre , Nnounces , Formation , Cientific , Strategy , Board , Liver , Disease , Experts ,